Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal

Author:

Dewidar OmarORCID,Lotfi Tamara,Langendam Miranda,Parmelli Elena,Saz Parkinson Zuleika,Solo KarlaORCID,Chu Derek KORCID,Mathew Joseph L,Akl Elie A,Brignardello-Petersen Romina,Mustafa Reem A,Moja Lorenzo,Iorio Alfonso,Chi Yuan,Canelo-Aybar Carlos,Kredo TamaraORCID,Karpusheff Justine,Turgeon Alexis F,Alonso-Coello Pablo,Wiercioch Wojtek,Gerritsen Annette,Klugar MiloslavORCID,Rojas María Ximena,Tugwell Peter,Welch Vivian AndreaORCID,Pottie Kevin,Munn Zachary,Nieuwlaat Robby,Ford Nathan,Stevens Adrienne,Khabsa JoanneORCID,Nasir Zil,Leontiadis Grigorios I,Meerpohl Joerg J,Piggott ThomasORCID,Qaseem Amir,Matthews Micayla,Schünemann Holger JORCID

Abstract

ObjectivesTo evaluate the development and quality of actionable statements that qualify as good practice statements (GPS) reported in COVID-19 guidelines.Design and settingSystematic review . We searched MEDLINE, MedSci, China National Knowledge Infrastructure (CNKI), databases of Grading of Recommendations Assessment, Development and Evaluation (GRADE) Guidelines, NICE, WHO and Guidelines International Network (GIN) from March 2020 to September 2021. We included original or adapted recommendations addressing any COVID-19 topic.Main outcome measuresWe used GRADE Working Group criteria for assessing the appropriateness of issuing a GPS: (1) clear and actionable; (2) rationale necessitating the message for healthcare practice; (3) practicality of systematically searching for evidence; (4) likely net positive consequences from implementing the GPS and (5) clear link to the indirect evidence. We assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation II tool.Results253 guidelines from 44 professional societies issued 3726 actionable statements. We classified 2375 (64%) as GPS; of which 27 (1%) were labelled as GPS by guideline developers. 5 (19%) were labelled as GPS by their authors but did not meet GPS criteria. Of the 2375 GPS, 85% were clear and actionable; 59% provided a rationale necessitating the message for healthcare practice, 24% reported the net positive consequences from implementing the GPS. Systematic collection of evidence was deemed impractical for 13% of the GPS, and 39% explained the chain of indirect evidence supporting GPS development. 173/2375 (7.3%) statements explicitly satisfied all five criteria. The guidelines’ overall quality was poor regardless of the appropriateness of GPS development and labelling.ConclusionsStatements that qualify as GPS are common in COVID-19 guidelines but are characterised by unclear designation and development processes, and methodological weaknesses.

Funder

Canadian Institutes of Health Research

Publisher

BMJ

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3